Heparan Sulfate Regulates ADAM12 through a Molecular Switch Mechanism

The disintegrin and metalloproteases (ADAMs) are emerging as therapeutic targets in human disease, but specific drug design is hampered by potential redundancy. Unlike other metzincins, ADAM prodomains remain bound to the mature enzyme to regulate activity. Here ADAM12, a protease that promotes tumo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2008-11, Vol.283 (46), p.31920-31932
Hauptverfasser: Sørensen, Hans Peter, Vivès, Romain R., Manetopoulos, Christina, Albrechtsen, Reidar, Lydolph, Magnus C., Jacobsen, Jonas, Couchman, John R., Wewer, Ulla M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!